175 related articles for article (PubMed ID: 15152154)
21. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study.
Brasselet C; Durand E; Addad F; Vitry F; Chatellier G; Demerens C; Lemitre M; Garnotel R; Urbain D; Bruneval P; Lafont A
Eur Heart J; 2008 Feb; 29(3):402-12. PubMed ID: 18212388
[TBL] [Abstract][Full Text] [Related]
22. Brachytherapy for renal [corrected] artery in-stent restenosis.
Gupta R; Zoghbi G; Aqel R
J Invasive Cardiol; 2006 Aug; 18(8):E227-9. PubMed ID: 16877794
[TBL] [Abstract][Full Text] [Related]
23. Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries.
Ferrero V; Ribichini F; Heyndrickx GR; De Bruyne B; Piessens M; Carlier S; Büchi M; Matullo G; Vassanelli C; Wijns W
Am J Cardiol; 2004 Nov; 94(10):1237-42. PubMed ID: 15541237
[TBL] [Abstract][Full Text] [Related]
24. Intravascular ultrasound-guided cutting balloon angioplasty for renal artery stent restenosis.
Otah KE; Alhaddad IA
Clin Cardiol; 2004 Oct; 27(10):581-3. PubMed ID: 15553312
[TBL] [Abstract][Full Text] [Related]
25. Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial.
Ribichini F; Ferrero V; Piessens M; Heyndrickx GR; de Bruyne B; Verbeke L; Matullo G; Büchi M; Piazza A; Guarrera S; Lüscher TF; Wijns W
Cardiovasc Revasc Med; 2005; 6(1):7-13. PubMed ID: 16263350
[TBL] [Abstract][Full Text] [Related]
26. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
[TBL] [Abstract][Full Text] [Related]
27. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
[TBL] [Abstract][Full Text] [Related]
28. Restenosis following percutaneous renal artery revascularization.
Kane GC; Hambly N; Textor SC; Stanson AW; Garovic VD
Nephron Clin Pract; 2007; 107(2):c63-9. PubMed ID: 17848809
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
Dibra A; Kastrati A; Alfonso F; Seyfarth M; Pérez-Vizcayno MJ; Mehilli J; Schömig A
J Am Coll Cardiol; 2007 Feb; 49(5):616-23. PubMed ID: 17276188
[TBL] [Abstract][Full Text] [Related]
30. Covered stent for the treatment of recurrent bilateral renal artery in-stent restenosis.
Yan BP; Kiernan TJ; Rosenfield K
J Invasive Cardiol; 2008 Oct; 20(10):E288-92. PubMed ID: 18830008
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous vascular interventions in renal artery diseases.
Kolluri R; Goldstein JA; Rocha-Singh K
Minerva Cardioangiol; 2006 Feb; 54(1):95-107. PubMed ID: 16467745
[TBL] [Abstract][Full Text] [Related]
32. [Intravascular brachytherapy in the prevention of vascular restenosis].
Dvorák J; Petera J; Fridrich J; Raupach J; Krajina A; Hůlek P; Melichar B; Malý J
Cas Lek Cesk; 2003 Mar; 142(3):154-6. PubMed ID: 12756843
[TBL] [Abstract][Full Text] [Related]
33. Use of SafeCut Balloon for treatment of in-stent restenosis of a previously underexpanded sirolimus-eluting stent with a heavily calcified plaque.
Otsuka Y; Kasahara Y; Kawamura A
J Invasive Cardiol; 2007 Dec; 19(12):E359-62. PubMed ID: 18180527
[TBL] [Abstract][Full Text] [Related]
34. Very late drug-eluting stent thrombosis and cardiogenic shock: 1,249 days after implantation.
Chen JP
J Invasive Cardiol; 2007 Dec; 19(12):E381-4. PubMed ID: 18180534
[TBL] [Abstract][Full Text] [Related]
35. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects.
Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY
Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449
[TBL] [Abstract][Full Text] [Related]
36. In-stent restenosis after carotid angioplasty and stenting: a challenge for the vascular surgeon.
Setacci C; de Donato G; Setacci F; Pieraccini M; Cappelli A; Trovato RA; Benevento D
Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):601-7. PubMed ID: 15878537
[TBL] [Abstract][Full Text] [Related]
37. Current thoughts on the management of renovascular disease.
Hines GL
Heart Dis; 2000; 2(2):118-23. PubMed ID: 11728249
[TBL] [Abstract][Full Text] [Related]
38. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
39. In-stent restenosis of the renal artery in a single kidney patient: the role of ACEI in the therapeutic choice.
Cianci R; Gigante A; Polidori L; Di Donato D; Martina P; Barbano B; Renzulli R; Zaccaria A; Fuiano G
Angiology; 2009; 60(4):496-503. PubMed ID: 18796449
[TBL] [Abstract][Full Text] [Related]
40. First use of cryoplasty to treat in-stent renal artery restenosis.
Jefferies JL; Dougherty K; Krajcer Z
Tex Heart Inst J; 2008; 35(3):352-5. PubMed ID: 18941646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
